FDA has established the Nanotechnology Characterization Laboratory (NCL) in collaboration with the National Institute of Standards and Technology (NIST) and the National Cancer Institute to perform preclinical efficacy and toxicity testing of nanoparticles. NCL can provide the infrastructure to accelerate ...